Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leylah M Drusbosky

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
International Journal of Molecular Sciences|May 14, 2020
Identification of Lenalidomide Sensitivity and Resistance Mechanisms in Non-Del(5q) Myelodysplastic SyndromesLeylah M Drusbosky, Christopher R Cogle
Current Hematologic Malignancy Reports|September 16, 2017
Computational Modeling and Treatment Identification in the Myelodysplastic SyndromesLeylah M Drusbosky, Christopher R Cogle
Journal of Hematology & Oncology|March 27, 2021
Therapeutic strategies in RET gene rearranged non-small cell lung cancerLeylah M Drusbosky, Estelamari Rodriguez, Richa Dawar, et al.
Journal of Hematology & Oncology|August 24, 2021
Therapeutic strategies in METex14 skipping mutated non-small cell lung cancerLeylah M Drusbosky, Richa Dawar, Estelamari Rodriguez, et al.
Translational Behavioral Medicine|May 26, 2018
Using social media to assess care coordination goals and plans for leukemia patients and survivorsYulia A Strekalova, Kimberly E Hawkins, Leylah M Drusbosky, et al.
Case Reports in Oncology|March 29, 2021
Detection of Microsatellite Instability via Circulating Tumor DNA and Response to Immunotherapy in Metastatic Castration-Resistant Prostate Cancer: A Case SeriesDeepak Ravindranathan, Greta Anne Russler, Lauren Yantorni, et al.
Clinical Lung Cancer|August 12, 2022
Oncogene Overlap Analysis of Circulating Cell-free Tumor DNA to Explore the Appropriate Criteria for Defining MET Copy Number-Driven Lung CancerDavid C C Tsui, Leylah M Drusbosky, Sara Wienke, et al.
Cancers|July 13, 2024
Sex- and Age-Associated Differences in Genomic Alterations among Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)ErinMarie O Kimbrough, Julian A Marin-Acevedo, Leylah M Drusbosky, et al.
The Prostate|June 29, 2022
Elevated serum CEA is associated with liver metastasis and distinctive circulating tumor DNA alterations in patients with castration-resistant prostate cancerAlexander W Bray, Rong Duan, Pannaga Malalur, et al.
Frontiers in Oncology|March 7, 2024
Genomic amplifications identified by circulating tumor DNA analysis guide prognosis in metastatic castration-resistant prostate cancerToros A Dincman, Joseph A Q Karam, Antonio Giordano, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
International Journal of Molecular Sciences|May 14, 2020
Identification of Lenalidomide Sensitivity and Resistance Mechanisms in Non-Del(5q) Myelodysplastic SyndromesLeylah M Drusbosky, Christopher R Cogle
Current Hematologic Malignancy Reports|September 16, 2017
Computational Modeling and Treatment Identification in the Myelodysplastic SyndromesLeylah M Drusbosky, Christopher R Cogle
Journal of Hematology & Oncology|March 27, 2021
Therapeutic strategies in RET gene rearranged non-small cell lung cancerLeylah M Drusbosky, Estelamari Rodriguez, Richa Dawar, et al.
Journal of Hematology & Oncology|August 24, 2021
Therapeutic strategies in METex14 skipping mutated non-small cell lung cancerLeylah M Drusbosky, Richa Dawar, Estelamari Rodriguez, et al.
Translational Behavioral Medicine|May 26, 2018
Using social media to assess care coordination goals and plans for leukemia patients and survivorsYulia A Strekalova, Kimberly E Hawkins, Leylah M Drusbosky, et al.
Case Reports in Oncology|March 29, 2021
Detection of Microsatellite Instability via Circulating Tumor DNA and Response to Immunotherapy in Metastatic Castration-Resistant Prostate Cancer: A Case SeriesDeepak Ravindranathan, Greta Anne Russler, Lauren Yantorni, et al.
Clinical Lung Cancer|August 12, 2022
Oncogene Overlap Analysis of Circulating Cell-free Tumor DNA to Explore the Appropriate Criteria for Defining MET Copy Number-Driven Lung CancerDavid C C Tsui, Leylah M Drusbosky, Sara Wienke, et al.
Cancers|July 13, 2024
Sex- and Age-Associated Differences in Genomic Alterations among Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)ErinMarie O Kimbrough, Julian A Marin-Acevedo, Leylah M Drusbosky, et al.
The Prostate|June 29, 2022
Elevated serum CEA is associated with liver metastasis and distinctive circulating tumor DNA alterations in patients with castration-resistant prostate cancerAlexander W Bray, Rong Duan, Pannaga Malalur, et al.
Frontiers in Oncology|March 7, 2024
Genomic amplifications identified by circulating tumor DNA analysis guide prognosis in metastatic castration-resistant prostate cancerToros A Dincman, Joseph A Q Karam, Antonio Giordano, et al.
Pageof 3